VION! NEWS ! News for 'VION' - (DJ CORRECT: Vion Licenses Melasyn Rights To Johnson & Johnson)
Vion Pharmaceuticals Inc. (VION) is licensing its Melasyn technology to Johnson & Johnson (JNJ). (A headline at at 8:32 a.m. EST misstated Vion was licensing the rights from J&J.)
(END) Dow Jones Newswires 03-15-04 0913ET- - 09 13 AM EST 03-15-04
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.